Back
Guardant Health Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
46
GH
Guardant Health
Last Price:
18.18
Seasonality Move:
10.58%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
43.99
Seasonality Move:
10.8%
Sell
46
Guardant Health (GH)
is a Sell
Is Guardant Health a Buy, Sell or Hold?
- The current Guardant Health [GH] share price is $17.35. The Score for GH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- GH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GH Stock Price Chart
What is Guardant Health's stock price today?
-
The Guardant Health share price today is $17.35
The current trend is relatively stagnant and GH is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $44.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
GH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 46.1 | Sell |
Chaikin Money Flow: | 380999 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.75 - 19.33) | Sell |
Bollinger Bands (100): | (18.18 - 25.54) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 43.92 | Sell |
Chaikin Money Flow: | 101540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.49 - 48.87) | Sell |
Bollinger Bands (100): | (43.62 - 49.46) | Sell |
GH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.09 | Buy |
20-day SMA: | 18.02 | Sell |
50-day SMA: | 18.77 | Sell |
200-day SMA: | 26.38 | Sell |
8-day EMA: | 17.36 | Sell |
20-day EMA: | 17.74 | Sell |
50-day EMA: | 19.01 | Sell |
200-day EMA: | 24.97 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.87 | Buy |
20-day SMA: | 46.21 | Sell |
50-day SMA: | 47.79 | Sell |
200-day SMA: | 42.13 | Buy |
8-day EMA: | 44.35 | Sell |
20-day EMA: | 45.49 | Sell |
50-day EMA: | 46.38 | Sell |
200-day EMA: | 44.57 | Sell |
Guardant Health Earnings Growth & GH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.03 per share, an increase this year of $0.58 per share, and an increase next year of $0.32 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.
Guardant Health Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |